BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar A, Zhou L, Zhi K, Raji B, Pernell S, Tadrous E, Kodidela S, Nookala A, Kochat H, Kumar S. Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles. Int J Mol Sci 2020;22:E138. [PMID: 33375558 DOI: 10.3390/ijms22010138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Raghav A, Singh M, Jeong G, Giri R, Agarwal S, Kala S, Gautam KA. Extracellular vesicles in neurodegenerative diseases: A systematic review. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.1061076] [Reference Citation Analysis]
2 Bahadur S, Jha MK. Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103932] [Reference Citation Analysis]
3 Kumar S, Singla B, Singh AK, Thomas-gooch SM, Zhi K, Singh UP. Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options. Cells 2022;11:2620. [DOI: 10.3390/cells11172620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Calatroni M, Moroni G, Reggiani F, Ponticelli C. Renal sarcoidosis. J Nephrol 2022. [PMID: 35761015 DOI: 10.1007/s40620-022-01369-y] [Reference Citation Analysis]
5 Raffaini G, Catauro M. Surface Interactions between Ketoprofen and Silica-Based Biomaterials as Drug Delivery System Synthesized via Sol–Gel: A Molecular Dynamics Study. Materials 2022;15:2759. [DOI: 10.3390/ma15082759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhou L, Kodidela S, Godse S, Thomas-gooch S, Kumar A, Raji B, Zhi K, Kochat H, Kumar S. Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles. Pharmaceuticals 2022;15:358. [DOI: 10.3390/ph15030358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kodidela S, Godse S, Kumar A, Nguyen XH, Cernasev A, Zhou L, Singh AK, Bhat HK, Kumar S. Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality. Biology 2022;11:177. [DOI: 10.3390/biology11020177] [Reference Citation Analysis]
8 Gómez O, Perini-Villanueva G, Yuste A, Rodríguez-Navarro JA, Poch E, Bejarano E. Autophagy and Glycative Stress: A Bittersweet Relationship in Neurodegeneration. Front Cell Dev Biol 2021;9:790479. [PMID: 35004686 DOI: 10.3389/fcell.2021.790479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wu XY, Liao BY, Xiao D, Wu WC, Xiao Y, Alexander T, Song SJ, Zhao ZH, Zhang Y, Wang ZH, Wang LB, Li X. Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis. Biomater Sci 2021. [PMID: 34928285 DOI: 10.1039/d1bm01142a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kumar S, Kumar P, Kodidela S, Duhart B, Cernasev A, Nookala A, Kumar A, Singh UP, Bissler J. Racial Health Disparity and COVID-19. J Neuroimmune Pharmacol 2021. [PMID: 34499313 DOI: 10.1007/s11481-021-10014-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 D'Mello SR. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease. Int J Mol Sci 2021;22:5911. [PMID: 34072862 DOI: 10.3390/ijms22115911] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
12 Ananbeh H, Vodicka P, Kupcova Skalnikova H. Emerging Roles of Exosomes in Huntington's Disease. Int J Mol Sci 2021;22:4085. [PMID: 33920936 DOI: 10.3390/ijms22084085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
13 Zhi K, Raji B, Nookala AR, Khan MM, Nguyen XH, Sakshi S, Pourmotabbed T, Yallapu MM, Kochat H, Tadrous E, Pernell S, Kumar S. PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP. Pharmaceutics 2021;13:500. [PMID: 33917577 DOI: 10.3390/pharmaceutics13040500] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
14 Saghazadeh A, Rezaei N. Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19. Emergent Mater 2021;:1-20. [PMID: 33718777 DOI: 10.1007/s42247-021-00192-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]